LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) Institutional Ownership

CUSIP: 503459604

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2022

Type / Class
Equity / COM PAR $.0001 2
Symbol
LJPC
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$53,857,000 0
2022 Q2 16,883,918 $53,857,003 +$1,089,648 $3.19 37
2022 Q1 16,494,972 $70,431,274 -$723,442 $4.27 44
2021 Q4 16,737,185 $77,825,563 -$4,174,504 $4.65 44
2021 Q3 17,780,491 $70,939,779 -$2,441,335 $3.99 51
2021 Q2 18,361,700 $78,585,321 -$10,292,851 $4.28 59
2021 Q1 20,791,737 $88,153,113 +$2,127,920 $4.24 74
2020 Q4 20,340,507 $78,922,026 -$128,678 $3.88 62
2020 Q3 20,367,198 $82,067,411 +$507,557 $4.03 64
2020 Q2 20,191,489 $86,007,135 +$5,502,028 $4.26 74
2020 Q1 18,898,994 $79,373,762 +$8,959,956 $4.20 69
2019 Q4 19,552,299 $76,836,766 -$51,387,886 $3.93 73
2019 Q3 24,855,468 $218,907,700 -$22,107,862 $8.80 73
2019 Q2 27,307,537 $252,397,930 +$23,200,956 $9.25 77
2019 Q1 25,401,782 $163,398,713 -$70,703,731 $6.43 78
2018 Q4 31,288,325 $295,494,316 -$23,418,111 $9.43 80
2018 Q3 33,282,583 $669,977,036 +$52,028,815 $20.13 75
2018 Q2 26,420,197 $770,711,392 +$38,609,701 $29.17 91
2018 Q1 25,103,513 $747,596,219 +$95,513,840 $29.78 98
2017 Q4 21,671,783 $697,451,459 +$39,843,841 $32.18 92
2017 Q3 23,821,204 $828,494,536 -$6,498,436 $34.78 95
2017 Q2 24,111,272 $717,952,134 +$76,434,629 $29.77 82
2017 Q1 22,501,974 $671,891,030 +$226,951,459 $29.85 96
2016 Q4 15,918,221 $279,081,656 -$5,685,317 $17.53 62
2016 Q3 16,098,330 $382,887,182 +$5,880,405 $23.79 70
2016 Q2 15,972,246 $255,675,832 -$9,198,138 $16.00 72
2016 Q1 16,134,183 $337,146,000 +$1,728,873 $20.91 66
2015 Q4 15,932,309 $430,390,906 -$4,300,114 $27.00 78
2015 Q3 16,084,261 $446,797,865 +$144,681,607 $27.79 72
2015 Q2 10,873,590 $266,508,413 +$20,866,245 $24.51 52
2015 Q1 10,079,423 $184,459,660 +$9,567,944 $18.30 37
2014 Q4 9,553,084 $176,251,000 +$15,991,918 $18.45 33
2014 Q3 7,497,961 $72,055,000 +$40,347,558 $9.61 28
2014 Q2 3,302,137 $30,310,000 +$16,513,855 $9.18 21
2014 Q1 1,453,162 $15,694,000 +$15,472,000 $10.80 24